BMY
Bristol-Myers Squibb Company
BMY Institutional Purchase & Sale
Bristol-Myers Squibb Company Buys & Sells (2021 Q2)
- # of activities:
- 8
- AVG reported price*:
- $66.61
- Current price*:
- +1.05%($67.31)
8 value investing gurus have made changes to the Bristol-Myers Squibb Company (BMY) position according to the gurus' 2021 Q2 SEC quarterly report(s). The number of BMY shares has been increased by 4, decreased by 4 super investor(s).
Which gurus or hedge funds bought BMY in 2021 Q2?
According to the 2021 Q2 SEC filing(s) Bristol-Myers Squibb Company (BMY) has been bought by 4 gurus / funds: Ole Andreas Halvorsen - Viking Global Investors (added shares +117.84%), Independent Franchise Partners - US Equity Fund (added shares +18.74%), Kahn Brothers Group (added shares +5.52%) and Ronald Muhlenkamp - Muhlenkamp & Co (added shares +0.16%).
To see more about who is investing in Bristol-Myers Squibb Company (BMY), please go to the BMY ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".